Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
12/01/2011 | US20110294165 Variant humicola grisea cbh1.1 |
12/01/2011 | US20110294164 Variant humicola grisea cbh1.1 |
12/01/2011 | US20110294149 Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor |
12/01/2011 | US20110294147 Serological screening for hhv-8 infection using antigen mixtures |
12/01/2011 | US20110294145 Reagents and methods for detecting a polymorphic protein |
12/01/2011 | US20110294137 Sensor |
12/01/2011 | US20110294128 Concentration and Enrichment of Microbial Cells and Microbial Nucleic Acids from Bodily Fluids |
12/01/2011 | US20110294127 Elite event a2704-12 and methods and kits for identifying such event in biological samples |
12/01/2011 | US20110294124 Method for the synthesis of phosphorus atom modified nucleic acids |
12/01/2011 | US20110294123 Methods for diagnosing or treating prostate cancer |
12/01/2011 | US20110294120 Probes for Detection of SULT1A1 Gene, Reagent Containing the Same, and the Uses Thereof |
12/01/2011 | US20110294119 Novel methods of differentiating yeast strains and/or determining genetic stability of yeast strains, and uses thereof |
12/01/2011 | US20110294118 Water soluble fluorescent compounds |
12/01/2011 | US20110294114 Optimization of determinants for successful genetic correction of diseases, mediated by hematopoietic stem cells |
12/01/2011 | US20110293815 Corn plants and seed enhanced for asparagine and protein |
12/01/2011 | US20110293708 Process for preparing purified nucleic acid and the use thereof |
12/01/2011 | US20110293703 Aminoalcohol lipidoids and uses thereof |
12/01/2011 | US20110293702 Compounds and Methods for the Treatment of Inflammatory Diseases of the CNS |
12/01/2011 | US20110293698 Reagents and Methods for Treating Cancer |
12/01/2011 | US20110293664 Chlamydia antigens and uses thereof |
12/01/2011 | US20110293656 Recombinant mva capable of expressing structural hcv antigens |
12/01/2011 | US20110293652 Chimeric ospa genes, proteins, and methods of use thereof |
12/01/2011 | US20110293650 Influenza virus-like particles (vlps) comprising hemagglutinin |
12/01/2011 | US20110293645 Wdrpuh epitope peptides and vaccines containing the same |
12/01/2011 | US20110293644 Compositions and methods for treatment of celiac disease |
12/01/2011 | US20110293624 Genes of an Otitis Media Isolate of NonTypeable Haemophilus Influenzae |
12/01/2011 | US20110293621 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof |
12/01/2011 | US20110293620 Monoclonal Antibodies For Use In Diagnosis and Therapy of Cancers and Autoimmune Disease |
12/01/2011 | US20110293619 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
12/01/2011 | US20110293618 Anti-human clcp1 antibody and use thereof |
12/01/2011 | US20110293617 Anti-p-selectin antibodies and methods of their use and identification |
12/01/2011 | US20110293613 Bispecific antibodies |
12/01/2011 | US20110293610 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
12/01/2011 | US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity |
12/01/2011 | US20110293608 Annexin a2 as immunological target |
12/01/2011 | US20110293599 Method for modulating muscle differentiation or regeneration |
12/01/2011 | US20110293597 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders |
12/01/2011 | US20110293587 Glucagon analogues |
12/01/2011 | US20110293586 Glucagon analogues |
12/01/2011 | US20110293585 Compositions and methods for treatment of lysosomal storage disorders |
12/01/2011 | US20110293579 Bi-specific fusion proteins |
12/01/2011 | US20110293566 Diffocin and methods of use thereof |
12/01/2011 | US20110293565 Novel synthetic agonists of tlr9 |
12/01/2011 | US20110293557 Conjugates for the administration of biologically active compounds |
12/01/2011 | CA2799501A1 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups |
11/30/2011 | EP2390259A2 Amplification and detection reagents for HIV-1 |
11/30/2011 | EP2390258A1 High fidelity polymerases and uses thereof |
11/30/2011 | EP2390256A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
11/30/2011 | EP2389455A1 Methods and compositions for identifying a fetal cell |
11/30/2011 | EP2389454A1 Method for enrichment of selected rna molecules |
11/30/2011 | EP1633372B1 Vaccines, immunotherapeutics and methods for using the same |
11/30/2011 | EP1075544B1 Chemically modified nucleic acids and methods for coupling nucleic acids to solid support |
11/30/2011 | CN1656222B 反义iap核碱基寡聚物及其应用 Iap nucleobase antisense oligomer and its application |
11/30/2011 | CN102264914A 用于修饰核酸的转座子末端组合物和方法 Transposon terminus modified nucleic acid compositions and methods for |
11/30/2011 | CN102264899A 弯曲的玻璃表面上的核酸提取 Extraction of nucleic acids on the curved surface of the glass |
11/30/2011 | CN102264374A 5′和2′双取代的核苷和由其制备的低聚化合物 5 'and 2' substituted nucleoside and double oligomeric compounds prepared therefrom |
11/29/2011 | US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof |
11/29/2011 | US8067672 Flower tissue-specific promoter and uses thereof |
11/29/2011 | US8067670 Plants that produce amylopectin starch with novel properties |
11/29/2011 | US8067581 Biomolecules having multiple attachment moieties for binding to a substrate surface |
11/29/2011 | US8067580 Isolation of DNA, RNA and protein from a single sample |
11/29/2011 | US8067579 Nucleic acid extraction method |
11/29/2011 | US8067578 Substrate preparation process |
11/29/2011 | US8067577 Methods and compositions for the treatment of intestinal conditions |
11/29/2011 | US8067576 siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase) |
11/29/2011 | US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA) |
11/29/2011 | US8067574 Nucleic acid agents for downregulating H19, and methods of using same |
11/29/2011 | US8067573 Nucleic acid agents for downregulating H19 and methods of using same |
11/29/2011 | US8067572 Hybrid interfering RNA |
11/29/2011 | US8067571 Conjugating an arginine-rich carrier to a 3' or 5' end; phosphorodiamidate linkages |
11/29/2011 | US8067570 Therapeutic uses of inhibitors of RTP801 |
11/29/2011 | US8067569 Splice-region antisense composition and method |
11/29/2011 | US8067568 Method for diagnosing spinal muscular atrophy |
11/29/2011 | US8067567 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
11/29/2011 | US8067564 Methods of obtaining a specific binding member that binds eotaxin |
11/29/2011 | US8067563 Tumor suppressor gene, p471NG3 |
11/29/2011 | US8067562 Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1 |
11/29/2011 | US8067561 Isolated DNA encoding recombinant glucose isomerase |
11/29/2011 | US8067560 SRSV detection kit |
11/29/2011 | US8067559 Yeast-based vaccines as immunotherapy |
11/29/2011 | US8067558 Constitutively active fragments of eukaryotic heat shock RNA |
11/29/2011 | US8067557 OCL-2A3 compositions and uses thereof |
11/29/2011 | US8067556 Multi-site mutagenesis |
11/29/2011 | US8067538 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium |
11/29/2011 | US8067529 Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
11/29/2011 | US8067389 Silencing of TGFβ type II receptor expression by siRNA |
11/29/2011 | US8067388 Decoy-containing pharmaceutical compositions and method of using the same |
11/29/2011 | US8067386 Modulation of eIF4E-BP2 expression |
11/29/2011 | US8067385 Antiviral oligonucleotides targeting HBV |
11/29/2011 | US8067239 Reagents for recombinogenic engineering and use thereof |
11/29/2011 | US8067236 Optimized human T1R3 nucleic acid molecule |
11/29/2011 | US8067235 Optimized human T1R2 nucleic acid molecule |
11/29/2011 | US8067231 Clostridial toxin activity assays |
11/29/2011 | US8067227 Viral vectors and the use of the same for gene therapy |
11/29/2011 | US8067221 Von Willebrand factor (vWF)-cleaving protease |
11/29/2011 | US8067219 Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide |
11/29/2011 | US8067211 Method for production of L-glutamine |
11/29/2011 | US8067210 Method of producing lysine by culturing a host cell expressing a polynucleotide encoding a feedback resistant aspartokinase from corynebacterium |
11/29/2011 | US8067207 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
11/29/2011 | US8067197 Soluble recombinant αvβ3 adhesion receptor |